Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/3902
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDzantor, E. K-
dc.contributor.authorAsumah, M. N.-
dc.contributor.authorInusah, A.-W.-
dc.contributor.authorNukpezah, N. R.-
dc.contributor.authorAgyeman, Y. N.-
dc.contributor.authorKukeba, M. W.-
dc.contributor.authorBraimah, B. A.-
dc.contributor.authorAdjeso, T.-
dc.contributor.authorTahiru, M. M.-
dc.date.accessioned2023-02-14T11:59:39Z-
dc.date.available2023-02-14T11:59:39Z-
dc.date.issued2022-
dc.identifier.issn2054-1058-
dc.identifier.urihttp://hdl.handle.net/123456789/3902-
dc.description.abstractAim: The study examined the associated adverse events following SARS-CoV-2 vacci nation among healthcare workers during the first dose of the vaccine in the Northern Region of Ghana. Design: The study was a cross-sectional survey involving 463 healthcare workers. Method: The data were collected using a structured questionnaire. The data were analysed descriptively, and binary logistics was performed using SPSS version 25. Results: The mean age was 33.4 ± 9.7 years, the majority (43.6%) being ≤30 years and males (57.2%). The self-reported prevalence of SARS-CoV-2 vaccine adverse events was 75.5%. Common systemic adverse events comprised headache (47.5%), dizziness (18.4%) and local adverse events included generalized body pains (44.0%) and abscess around the injection sites (11.2%). The study found a high prevalence of self-reported SARS-CoV-2 vaccine adverse events involving both systemic and local adverse events. Our study gives useful information that can be used for public health-targeted inter ventions to boost public confidence in SARS-CoV-2 vaccines.en_US
dc.language.isoenen_US
dc.publisherJohn Wiley & Sons Incen_US
dc.relation.ispartofseriesVol.10;Issue 3-
dc.subjectadverse eventsen_US
dc.subjectfirst doseen_US
dc.subjecthealthcare workersen_US
dc.subjectSARS-CoV-2en_US
dc.subjectvaccineen_US
dc.titleADVERSE EVENTS REPORTED AFTER FIRST DOSE OF SARS-COV-2 VACCINE IN THE NORTHERN REGION OF GHANAen_US
dc.typeArticleen_US
Appears in Collections:School of Allied Health Sciences



Items in UDSspace are protected by copyright, with all rights reserved, unless otherwise indicated.